pharmaceutical investing Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA
pharmaceutical investing Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava as a Treatment for Complicated Intra-Abdominal Infections
LaFleur Minerals Closes $1.66 Million Flow-Through Offering to Advance Drilling and PEA-Related Work at its Swanson Gold Deposit
